Literature DB >> 18952160

Anti-inflammatory effects of Z23 on LPS-induced inflammatory responses in RAW264.7 macrophages.

Xu-Dong Hu1, Yang Yang, Xiang-Gen Zhong, Xiang-Hua Zhang, Yi-Nan Zhang, Zong-Ping Zheng, Yu Zhou, Wei Tang, Yi-Fu Yang, Li-Hong Hu, Jian-Ping Zuo.   

Abstract

AIM OF THE STUDY: Fissistigma oldhamii (Hemsl.) Merr, a traditional Chinese herb medicine, is used for treating rheumatoid arthritis in China. In our previous study, an effective compound, 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl) ethyl] propenamide (Z23), from this herb has showed potent immunosuppressive effects both in vitro and in vivo. However, its anti-inflammatory effect and mechanism is still need to explore.
MATERIALS AND METHODS: We examined the in vitro effects of Z23 on the production of nitric oxide (NO), prostaglandin E2 (PGE2) and cytokines by lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages.
RESULTS: Z23 significantly decreased the production of PGE2, NO, tumour necrosis factor alpha (TNFalpha) and IL6 production. Inducible nitric oxide synthase (iNOS) and cyclooxygenase2 (COX2) gene expression were also significantly reduced.
CONCLUSIONS: These results demonstrated that Z23 exerted an anti-inflammatory effect through modulating the synthesis of several mediators and cytokines involved in the inflammatory process. This study provided evidence to understand the therapeutic effects of Fissistigma oldhamii (Hemsl.) Merr and indicated that Z23 has the potential for treatment of various inflammatory diseases where the overproduction of NO, PGE2 and inflammatory cytokines has been shown to play a role, e.g. rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952160     DOI: 10.1016/j.jep.2008.09.026

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages.

Authors:  Yan-Fang Xian; Yu-Cui Li; Siu-Po Ip; Zhi-Xiu Lin; Xiao-Ping Lai; Zi-Ren Su
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

2.  Panax Notoginseng flower saponins (PNFS) inhibit LPS-stimulated NO overproduction and iNOS gene overexpression via the suppression of TLR4-mediated MAPK/NF-kappa B signaling pathways in RAW264.7 macrophages.

Authors:  Xiao-Xu Peng; Shu-Hui Zhang; Xiao-Ling Wang; Ting-Jie Ye; Hua Li; Xiao-Feng Yan; Li Wei; Zhong-Ping Wu; Jing Hu; Chun-Pu Zou; You-Hua Wang; Xu-Dong Hu
Journal:  Chin Med       Date:  2015-07-01       Impact factor: 5.455

Review 3.  Raging the War Against Inflammation With Natural Products.

Authors:  Ali Attiq; Juriyati Jalil; Khairana Husain; Waqas Ahmad
Journal:  Front Pharmacol       Date:  2018-09-07       Impact factor: 5.810

4.  Inhibition of inflammatory mediators by neobavaisoflavone in activated RAW264.7 macrophages.

Authors:  Ewelina Szliszka; Dariusz Skaba; Zenon P Czuba; Wojciech Krol
Journal:  Molecules       Date:  2011-05-03       Impact factor: 4.411

5.  Anti-inflammatory Effect of Perilla frutescens (L.) Britton var. frutescens Extract in LPS-stimulated RAW 264.7 Macrophages.

Authors:  Hyun-Ah Lee; Ji-Sook Han
Journal:  Prev Nutr Food Sci       Date:  2012-06

6.  IN VIVO AND IN VITRO IMMUNOMODULATORY AND ANTI-INFLAMMATORY EFFECTS OF TOTAL FLAVONOIDS OF ASTRAGALUS.

Authors:  Ze Guo; Hong-Yan Xu; Lu Xu; Sha-Sha Wang; Xue-Mei Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-07-03

Review 7.  Annonaceae: Breaking the Wall of Inflammation.

Authors:  Ali Attiq; Juriyati Jalil; Khairana Husain
Journal:  Front Pharmacol       Date:  2017-10-20       Impact factor: 5.810

8.  A mechanistic study on the inhibition of bacterial growth and inflammation by Nerium oleander extract with comprehensive in vivo safety profile.

Authors:  Yousra Shafiq; Syed Baqir Shyum Naqvi; Ghazala H Rizwani; Muhammad Arif Asghar; Rabia Bushra; Sana Ghayas; Ahad Abdul Rehman; Muhammad Asif Asghar
Journal:  BMC Complement Med Ther       Date:  2021-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.